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Tuberculosis (TB) is a major cause of mortality from an infectious disease, globally affecting 9.6 million
cases, with 1.5 million deaths in 2014 [1]. In 2014, there were 273381 TB cases reported in the World
Health Organization (WHO) European region, and an estimated 33000 deaths [2]. Vulnerable populations
(i.e. individuals affected by discrimination, hostility or economic adversity), which often include migrants
and refugees, have an increased risk of suffering from TB disease [1, 3, 4]. If this is not efficiently addressed,
the exposure of these groups to Mycobacterium tuberculosis strains may lead to a rise in the number of
cases of disease and related deaths, as well as contributing to a further increase in drug-resistant TB cases.
Several factors have contributed to the increase of population mobility in the WHO European region [3].
This rise in the level of cross-border movement has increased the need for collaboration between national
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health systems. Sustainable and effective mechanisms are thus needed to coordinate interventions to
ensure quality-based prevention, diagnosis and treatment for TB and latent TB infection (LTBI) [5, 6].
These interventions represent both individual human rights (independent of legal or residential status of
the subject) and public health pre-requisites to control and eliminate TB, as well as to prevent further
development of multidrug-resistant (MDR)-TB and extensively drug-resistant TB [7, 8].
For undocumented migrants, there is an urgent need for policies that will facilitate easy access to TB
diagnosis and treatment, as well as stop deportation until the end of treatment. These interventions would be
both in the interest of the individual and of the community in terms of TB control and elimination [9–13].
In 2015, more than one million migrants and refugees reached Europe by land and sea. In the whole of 2014,
the figure was much lower (219000) [4, 14]. In spite of the resolutions and statements recently released by
WHO and the European Union [4, 15], little is known about the policies in force in the different countries
in Europe to manage TB and LTBI among refugees [16, 17].
The following points should be noted. 1) The refugees’ health is an integral part of the health of the wider
community, as well as a human right [3, 9]. 2) TB is neither highly virulent nor easily transmitted, and is
treatable, and therefore efforts should be implemented to detect and treat it promptly. Provision of treatment
is essential to break the transmission cycle. 3) Refugees who come from middle or high TB incidence
countries, as well as those from low TB incidence countries who have travelled and lived in precarious
conditions, have a higher risk of being infected and of developing TB than the population of the host
country [1, 3, 5, 6]. 4) The diagnosis of LTBI, TB and MDR-TB is not always easy to organise and perform
in the centres hosting refugees upon arrival in Europe [4, 16, 17] or as they travel through other countries.
5) Sub-optimal medical management of LTBI, TB and MDR-TB and/or inadequate follow-up of this mobile
population could undermine TB prevention and control among refugees and the host society [3, 9].
The European Respiratory Society and the European Region of the International Union Against TB and
Lung Disease urge health authorities, national and international technical agencies and civil society
organisations, as well as donor agencies, to prioritise TB care, prevention and control. They strongly
recommend: 1) adapting and implementing the principles of the WHO End TB Strategy to ensure adequate
prevention, diagnosis and treatment of TB (and of LTBI in the countries where these are offered) among
refugees [1, 5]; 2) providing quality surveillance, monitoring and evaluation, and operational research to
enhance TB prevention, control and care among refugees; 3) ensuring timely screening for active TB among
refugees coming from middle or high TB incidence countries; 4) avoiding stigmatisation and stereotypes of
both TB-infected people and vulnerable groups; 5) promoting universal access to prevention, diagnosis and
treatment services for LTBI (in the countries where these are offered) and TB, as well as to the necessary care
of existing comorbidities [1, 5]; and 6) ensuring quality infection control, including protective measures for
staff, and providing HIV testing and counselling to detect HIV and TB/HIV co-infected individuals [18, 19].
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